Tag: C-reactive protein testing market growth

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The C-Reactive Protein Testing Market Expected to Grow Between 2025 And 2029?

The market for c-reactive protein testing has experienced a consistent expansion in the past few years. It is projected to increase from a worth of $3.45 billion in 2024 to $3.52 billion in 2025, reflecting a compound annual growth rate (CAGR) of 2.0%. Factors contributing to this growth during the historical period include a rise in the incidence of inflammatory diseases, assessment of cardiovascular risk, a growing elderly population, improvements in healthcare infrastructure, and the implementation of healthcare screening programs.

Predictions indicate a consistent expansion in the size of the C-reactive protein testing market over the forthcoming years. It is anticipated to grow to a worth of $4.28 billion by 2029, with a compound annual growth rate (CAGR) of 5.0%. Factors contributing to this projected growth in the forecast period include increasing rates of obesity, the rise of personalized medicine along with biomarkers, advancements in telehealth and remote monitoring, earlier detection of diseases, and inflammation related to lifestyle choices. Key trends to look for in the forecast period encompass progress in diagnostic testing, the advent of wearable health technology, technological breakthroughs, strategic partnerships, and the onset of industry 4.0.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6719&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the C-Reactive Protein Testing Market?

The c-reactive protein testing market is anticipated to expand with the rise in cardiovascular disease (CVD) cases. These heart-related disorder encompass health issues such as vascular diseases, structural malfunctions, and hemostasis. While the precise cause of CVDs remains unknown, there could be multiple factors responsible for it. One such contributor could be behavioral risks emanating from unhealthy eating habits, sedentary lifestyle, smoking, and alcohol consumption, all of which lead to arteriosclerosis or plugging of arteries by fat deposits. This, in turn, enhances the blood clot risks alongside increased blood pressure, glucose levels, lipid levels, weight gain, and obesity. Thus, with CVD cases escalating, the necessity for c-reactive protein tests emerges to assess or predict the potential of developing cardiovascular issues equal to at least cholesterol level evaluations. To illustrate, the Institute for Health Metrics and Evaluation reported in December 2023 that global CVD-induced fatalities stood at 19.8 million in 2022, with ischemic heart disease claiming maximum lives at 108.8 per 100,000 individuals. Primarily, high systolic blood pressure accounted for the most disability-adjusted life years (DALYs) linked with CVD, and major behavioral and environmental influences causing this worldwide menace were dietary risks and air pollution.

Which Key Market Segments Comprise the C-Reactive Protein Testing Market and Drive Its Revenue Growth?

The c-reactive protein testingmarket covered in this report is segmented –

1) By Assay Type: Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Immunoturbidimetric Assays

2) By Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, Cancer, Other Applications

3) By End Use: Clinics, Hospitals, Diagnostic Laboratories

Subsegments:

1) By Enzyme-Linked Immunosorbent Assay (ELISA): Direct ELISA, Indirect ELISA, Sandwich ELISA

2) By Chemiluminescence Immunoassay (CLIA): Luminometer-Based CLIA, Automated CLIA Systems

3) By Immunoturbidimetric Assays: Nephelometry-Based Immunoturbidimetric Assays, Latex Agglutination Immunoturbidimetric Assays

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=6719&type=smp

Which Areas Are Leading Regions in the C-Reactive Protein Testing Market Expansion Across the Globe?

North America was the largest region in the c-reactive protein testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the c-reactive protein testing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Are the Key Market Trends in theC-Reactive Protein Testing Market Over the Coming Years?

One of the foremost trends within the c-reactive protein testing market is the progression in measurement technology. Big players in the industry are keen on integrating state-of-the-art tech solutions to cement their standing in the marketplace. By employing cutting-edge testing techniques, these industries are offering solutions that promise significant output and multiple applications. A case in point is Aidian, a diagnostics and testing solution firm from Finland. In February 2022, the company rolled out its QuikRead go wrCRP & wrCRP+Hb kits, which are designed to consistently deliver two types of results – a broad spectrum of CRP and Hb – from just one sample analysis. This extended spectrum CRP test enables the evaluation of neonatal sepsis, projecting the severity of COPD (chronic obstructive pulmonary disease), and aiding in cardiovascular risk computation.

View the full report here:

https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report

How Is the C-Reactive Protein Testing Market Conceptually Defined?

C-reactive protein testing measures the level of c-reactive protein (CRP) in the blood. CRP is a liver-produced protein released into the bloodstream due to inflammation. When the body is wounded or infected, inflammation is the body’s way of protecting the tissues. CRP testing is generally used to diagnose inflammation caused due to an infection.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6719

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the C-Reactive Protein Testing Market from 2024 to 2025?

Over the past few years, the size of the c-reactive protein testing market has seen consistent growth. The market is projected to expand from $3.45 billion in 2024 to $3.55 billion in 2025, with a compound annual growth rate (CAGR) of 2.9%. This upward trend during the historical period can be linked to factors such as the rising occurrence of inflammatory diseases, the assessment of cardiovascular risk, an aging population, enhanced healthcare infrastructure, and health screening initiatives.

What Is the Projected Market Size of the C-Reactive Protein Testing Market?

Expectations are high for the c-reactive protein testing market, which is anticipated to experience robust growth in the coming years. By 2029, the market is projected to reach $4.35 billion, with a compound annual growth rate (CAGR) of 5.2%. Contributing factors to this anticipated growth during the forecast period include an increase in obesity rates, advancements in personalized medicine and biomarkers, developments in telehealth and remote monitoring, precocious disease detection, and lifestyle-related inflammation. Key trends expected during the forecast period involve advancements in diagnostic testing, the rise of wearable health technology, entrance of technological solutions, strategic collaborations, and the roll-out of industry 4.0.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6719&type=smp

Who are the Major Competitors in the C-Reactive Protein Testing Market Outlook?

Major companies operating in the c-reactive protein testing market include Thermo Fisher Scientific Inc., F Hoffmann-La Roche AG, Danaher Corporation, Quest Diagnostics Incorporated, Siemens AG, Abbott Laboratories, Aidian Oy, Boditech Med Inc., Horiba Ltd., Laboratory Corporation, Merck KGAA, Randox Laboratories Limited, Getein Biotech Inc., Bio-Rad Laboratories Inc., DiaSorin S.p.A., Eurofins Scientific SE, Inova Diagnostics Inc., Luminex Corporation, Sekisui Diagnostics LLC, Sysmex Corporation, Tosoh Corporation, Trinity Biotech Plc, WerfenLife Group LLC, ZEUS Scientific Inc., BioMérieux SA, Biomerica Inc., Gold Standard Diagnostics Corp., Immunodiagnostic Systems Holdings PLC, Nova Biomedical Corporation

What Is Fueling Growth in the C-Reactive Protein Testing Market?

The rise in cardiovascular disease (CVD) instances is projected to spur the expansion of the c-reactive protein testing market. CVDs encompass conditions like diseased vessels, heart structure issues, and blood clots. The precise root cause of CVDs remains ambiguous, but several elements could heighten the probability of their onset. One such element is behavioral risks such as improper diet, inadequate physical exercise, smoking, and drinking, all of which contribute to fatty deposit build-up within the arteries (atherosclerosis), hence amplifying blood clot risks. These behavioral habits trigger an escalation in blood pressure, glucose, blood lipids, weight, and obesity. The amplified number of CVD occurrences underlines the requirement for c-reactive protein testing to assess or anticipate the chance of experiencing heart-related problems, much like cholesterol levels. For example, in December 2023, the Institute for Health Metrics and Evaluation reported reaching 19.8 million worldwide deaths from CVDs in 2022, with ischemic heart disease accounting for 108.8 deaths per 100,000 individuals. High systolic blood pressure was the largest contributor to disability-adjusted life years (DALYs) related to CVD, whereas dietary risks and air pollution were significant behavioral and environmental contributors to this global issue.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=6719&type=smp

Which C-Reactive Protein Testing Market Segments Are Growing the Fastest?

The c-reactive protein testing market covered in this report is segmented –

1) By Assay Type: Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Immunoturbidimetric Assays

2) By Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, Cancer, Other Applications

3) By End Use: Clinics, Hospitals, Diagnostic Laboratories

Subsegments:

1) By Enzyme-Linked Immunosorbent Assay (ELISA): Direct ELISA, Indirect ELISA, Sandwich ELISA

2) By Chemiluminescence Immunoassay (CLIA): Luminometer-Based CLIA, Automated CLIA Systems

3) By Immunoturbidimetric Assays: Nephelometry-Based Immunoturbidimetric Assays, Latex Agglutination Immunoturbidimetric Assays

Which Industry Trends Are Shaping the Future of the C-Reactive Protein Testing Market?

The surge in technology advancements in measuring tools is a notable trend unfolding in the c-reactive protein testing market. Leading firms in the sector are centering their efforts on offering state-of-the-art solutions with a view to cement their standing in the market. These organizations are incorporating avant-garde c-reactive testing techniques into their testing procedures and innovative solutions that promise perks like exceptional efficiency and assorted applications. To cite an example, in February 2022, Aidian, a company hailing from Finland that specializes in diagnostic tests and testing solutions, launched the QuikRead go wrCRP & wrCRP+Hb kits. This kit ensures the consistent delivery of dual results – a broad spectrum of CRP and Hb, obtained from a singular sample through one analysis. This broad spectrum CRP test enables the assessment of conditions such as neonatal sepsis, an estimation of the severity of diseases including COPD (chronic obstructive pulmonary disease), and provides assistance in carrying out cardiovascular risk assessments.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report

Which Countries Are Leading the C-Reactive Protein Testing Market?

North America was the largest region in the c-reactive protein testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the c-reactive protein testing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6719

This Report Delivers Insight On:

1. How big is the c-reactive protein testing market, and how is it changing globally?

2. Who are the major companies in the c-reactive protein testing market, and how are they performing?

3. What are the key opportunities and risks in the c-reactive protein testing market right now?

4. Which products or customer segments are growing the most in the c-reactive protein testing market?

5. What factors are helping or slowing down the growth of the c-reactive protein testing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theC-Reactive Protein Testing Market?

The surge in cardiovascular diseases (CVD) is anticipated to stimulate the expansion of the c-reactive protein testing market. CVD are heart-related issues such as impaired vessels, structural deficiencies, and blood coagulation. The precise trigger for CVD remains unknown, but there are several enhancing factors. One of these is behavior-related risk, which arises from poor diet, sedentary lifestyle, smoking, and alcohol consumption, leading to the buildup of fatty substances within the arteries (atherosclerosis). This contributes to the heightened risk of blood clots. Such behavior-driven risks result in increased blood pressure, glucose, blood lipids, weight gain, and obesity. The growing occurrence of cardiovascular illnesses necessitates c-reactive protein testing for the diagnosis or prediction of cardiovascular complications, on par with cholesterol levels at least. For example, in December 2023, the Institute for Health Metrics and Evaluation reported that global fatalities from cardiovascular diseases (CVDs) reached 19.8 million in 2022, with ischemic heart disease responsible for 108.8 deaths per 100,000 people. High systolic blood pressure was the major contributor to disability-adjusted life years (DALYs) related to CVD, while dietary risks and air pollution were key behavioral and environmental factors driving this global burden.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6719&type=smp

What is the Predicted Annual Growth Rate of theC-Reactive Protein Testing Market Impact Industry Trends by 2034?

Progressive growth has been witnessed in the size of the c-reactive protein testing market in the past few years. The market size, which was at $3.45 billion in 2024, is projected to increase to $3.55 billion in 2025, evidencing a compound annual growth rate (CAGR) of 2.9%. Factors such as the escalating prevalence of inflammatory diseases, assessment of cardiovascular risks, an enlarging elderly population, expansion in healthcare infrastructure, and the surge in healthcare screening programs have led to the augmented growth during the historical period.

The market for c-reactive protein testing is predicted to experience robust expansion in the coming years, reaching a value of $4.35 billion in 2029, with a compound annual growth rate (CAGR) of 5.2%. The catalysts for growth during the forecast period can be linked to surges in obesity levels, the development of personalized medicine and biomarkers, the rise of telehealth and remote monitoring, early detection of diseases, and lifestyle-related inflammation. Key trends to expect in the forecast period include advancements in diagnostic testing, wearable health technology, burgeoning technological solutions, strategic partnerships, and the advent of industry 4.0.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6719

What Are the Current Market Growth and Trends in theC-Reactive Protein Testing Market That Industry Players Should Watch?

Progress in technology applied to measuring tools is a prominent trend in the c-reactive protein testing market. The primary companies in this market are looking to enhance their market presence by offering solutions that incorporate cutting-edge technology. By integrating these next-generation techniques and innovative solutions into their testing methods, they aim to reap benefits such as increased efficiency and diverse applications. For instance, in February 2022, Aidian, a company based in Finland specializing in diagnostic tests and test solutions, introduced the QuikRead go wrCRP & wrCRP+Hb kits. These kits are capable of consistently delivering two results – a broad spectrum of CRP and Hb measurements – from a single sample following a single analysis. The broad-spectrum CRP test allows for useful assessments of conditions like neonatal sepsis, gauging disease severity in cases of COPD (chronic obstructive pulmonary disease), and aiding in cardiovascular risk evaluation.

What Are the Major Market Players Making an Impact on theC-Reactive Protein Testing Market Growth?

Major companies operating in the c-reactive protein testing market include Thermo Fisher Scientific Inc., F Hoffmann-La Roche AG, Danaher Corporation, Quest Diagnostics Incorporated, Siemens AG, Abbott Laboratories, Aidian Oy, Boditech Med Inc., Horiba Ltd., Laboratory Corporation, Merck KGAA, Randox Laboratories Limited, Getein Biotech Inc., Bio-Rad Laboratories Inc., DiaSorin S.p.A., Eurofins Scientific SE, Inova Diagnostics Inc., Luminex Corporation, Sekisui Diagnostics LLC, Sysmex Corporation, Tosoh Corporation, Trinity Biotech Plc, WerfenLife Group LLC, ZEUS Scientific Inc., BioMérieux SA, Biomerica Inc., Gold Standard Diagnostics Corp., Immunodiagnostic Systems Holdings PLC, Nova Biomedical Corporation

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report

How Are the Key Segments of the C-Reactive Protein Testing Market Driving Opportunities and Innovations?

The c-reactive protein testing market covered in this report is segmented –

1) By Assay Type: Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Immunoturbidimetric Assays

2) By Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, Cancer, Other Applications

3) By End Use: Clinics, Hospitals, Diagnostic Laboratories

Subsegments:

1) By Enzyme-Linked Immunosorbent Assay (ELISA): Direct ELISA, Indirect ELISA, Sandwich ELISA

2) By Chemiluminescence Immunoassay (CLIA): Luminometer-Based CLIA, Automated CLIA Systems

3) By Immunoturbidimetric Assays: Nephelometry-Based Immunoturbidimetric Assays, Latex Agglutination Immunoturbidimetric Assays

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=6719&type=smp

What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theC-Reactive Protein Testing Market?# Market Expansion?

North America was the largest region in the c-reactive protein testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the c-reactive protein testing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Gobal C-Reactive Protein Testing Maret 2025, By The Business Research Company:

Protein Expression Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/protein-expression-global-market-report

Oral Biologics & Biosimilar Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/oral-biologics-and-biosimilar-drug-global-market-report

Protein Labeling Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/protein-labelings-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the c-reactive protein testing market size evolved in recent years?

There has been a consistent expansion in the market size for c-reactive protein testing over the past years. The market is projected to rise from a value of $3.45 billion in 2024 to $3.55 billion in 2025, with a compound annual growth rate (CAGR) of 2.9%. The previously observed growth in this domain can be credited to factors such as a surge in inflammatory disease incidents, cardiovascular risk evaluations, an increased elderly population, enhancement of healthcare infrastructure, and implementation of healthcare screening initiatives.

What are the predictions for the c-reactive protein testing market size in the coming years?

The market for c-reactive protein testing is projected to experience significant expansion in the upcoming years. The market is forecasted to reach $4.35 billion in 2029, growing at a compound annual growth rate (CAGR) of 5.2%. This growth during the forecasted period could be linked to factors such as increasing obesity rates, personalized medicine and biomarkers, telehealth and remote patient monitoring, early detection of diseases, and inflammation related to lifestyle. Key trends observed during the forecast period are advancements in diagnostic testing, adoption of wearable health technology, technological solutions, strategic partnerships, and the emergence of the industry 4.0.

Get your c-reactive protein testing market report here!

https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report

What key factors are fueling the growth of the c-reactive protein testing market?

The escalating prevalence of cardiovascular diseases, including heart-related conditions such as blood clots and diseased vessels, is projected to fuel the expansion of the c-reactive protein testing market. The exact origin of CVD remains unknown, but several aspects, including behavior-related risks such as poor diet, sedentary lifestyle, smoking, and alcohol consumption can amplify the propensity to contract it. These behavioural habits can lead to accumulation of fat deposits within the arteries, enhanced probability of blood clots, high blood pressure, blood sugar and lipid levels, weight increase and obesity. Given the rising incidence of cardiovascular diseases, there is a pressing demand for c-reactive protein testing to ascertain or predict cardiovascular complications as effectively as cholesterol level checks. For example, in December 2023, the Institute for Health Metrics and Evaluation revealed that world-wide fatalities from cardiovascular diseases touched 19.8 million in 2022, with ischemic heart disease being the primary contributor with 108.8 fatalities per 100,000 individuals. High systolic blood pressure was the chief contributor to life years adjusted for disability related to CVD, while factors like dietary risks and air pollution were the significant behavioural and environmental drivers exacerbating this global issue.

How is the global c-reactive protein testing market divided into key segments?

The c-reactive protein testing market covered in this report is segmented –

1) By Assay Type: Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Immunoturbidimetric Assays

2) By Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, Cancer, Other Applications

3) By End Use: Clinics, Hospitals, Diagnostic Laboratories

Subsegments:

1) By Enzyme-Linked Immunosorbent Assay (ELISA): Direct ELISA, Indirect ELISA, Sandwich ELISA

2) By Chemiluminescence Immunoassay (CLIA): Luminometer-Based CLIA, Automated CLIA Systems

3) By Immunoturbidimetric Assays: Nephelometry-Based Immunoturbidimetric Assays, Latex Agglutination Immunoturbidimetric Assays

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6719&type=smp

Who are the key firms paving the way for growth in the c-reactive protein testing market?

Major companies operating in the c-reactive protein testing market include Thermo Fisher Scientific Inc., F Hoffmann-La Roche AG, Danaher Corporation, Quest Diagnostics Incorporated, Siemens AG, Abbott Laboratories, Aidian Oy, Boditech Med Inc., Horiba Ltd., Laboratory Corporation, Merck KGAA, Randox Laboratories Limited, Getein Biotech Inc., Bio-Rad Laboratories Inc., DiaSorin S.p.A., Eurofins Scientific SE, Inova Diagnostics Inc., Luminex Corporation, Sekisui Diagnostics LLC, Sysmex Corporation, Tosoh Corporation, Trinity Biotech Plc, WerfenLife Group LLC, ZEUS Scientific Inc., BioMérieux SA, Biomerica Inc., Gold Standard Diagnostics Corp., Immunodiagnostic Systems Holdings PLC, Nova Biomedical Corporation

Which trends are expected to transform the c-reactive protein testing market?

One significant trend observed in the c-reactive protein testing market is the surging innovations in measurement technology. To maintain and enhance their market dominance, primary players in this market are concentrating on the delivery of technologically sophisticated solutions. Such businesses have been integrating advanced c-reactive testing technologies into their testing procedures and devising enhanced solutions that offer maximum performance and multifunctionality. For instance, in February 2022, Aidian, a company based in Finland that specializes in diagnostic tests and test solutions, launched the QuikRead go wrCRP & wrCRP+Hb kits. These kits deliver dual results from one analysis of a single sample, encompassing a broad CRP and Hb range. The wide-range CRP test facilitates CRP measurement to analyze conditions such as neonatal sepsis, foretell the severity of COPD (chronic obstructive pulmonary disease), and contribute to cardiovascular risk evaluation.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6719

What regions are contributing significantly to the growth of the c-reactive protein testing market?

North America was the largest region in the c-reactive protein testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the c-reactive protein testing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Protein Expression Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/protein-expression-global-market-report

Oral Biologics & Biosimilar Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/oral-biologics-and-biosimilar-drug-global-market-report

Protein Labeling Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/protein-labelings-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Long-Term Growth Rate is Expected for the C-Reactive Protein Testing Market Between 2025 and 2034?

Over the past few years, the c-reactive protein testing market has seen a consistent increase in its size. It is predicted to expand from $3.45 billion in 2024 to $3.55 billion in 2025, experiencing a compound annual growth rate (CAGR) of 2.9%. This progression during the historic period is largely due to a rise in the occurrence of inflammatory diseases, assessments of cardiovascular risk, a growing elderly population, enhanced healthcare infrastructure, and the implementation of healthcare screening programs.

The market size of c-reactive protein testing is projected to witness substantial expansion in the upcoming years, expected to reach $4.35 billion by 2029, with a compound annual growth rate (CAGR) of 5.2%. This anticipated growth in the forecast period is linked with factors such as increasing rates of obesity, personalized medicine and biomarkers, the adoption of telehealth and remote monitoring, the emphasis on early detection of diseases, and lifestyle-related inflammation. Key trends expected during the forecast period encompass advancements in diagnostic testing, the advent of wearable health technology, technological solutions, strategic alliances, and the introduction of industry 4.0.

Which Macro and Microeconomic Factors Are Accelerating the Growth of the c-reactive protein testing Market?

The surge in cardiovascular disease (CVD) cases is anticipated to boost the c-reactive protein testing market. CVD encompasses heart-related conditions such as blood clots, diseased vessels, and structural problems. The precise origin of CVD is not clear, but many elements can escalate the likelihood of its occurrence. Behaviors like unbalanced diet, insufficient exercise, smoking, and alcohol consumption form one such risk factor, leading to a buildup of fatty plaques within the arteries (atherosclerosis), subsequently enhancing the chances of blood clots. Such behavioral risks lead to heightened blood pressure, sugar levels, blood lipids, weight gain and obesity. The growing prevalence of cardiovascular diseases necessitates c-reactive protein testing for diagnosis or to foresee the probability of cardiovascular concerns, at par or better than cholesterol level prediction. As an instance, the Institute for Health Metrics and Evaluation cited in December 2023 that global mortalities from CVDs had hit 19.8 million in 2022, with ischemic heart disease being the primary cause with 108.8 deaths per 100,000 individuals. Higher systolic blood pressure was the largest contributor to disability-adjusted life years (DALYs) linked to CVD, while dietary risks and air pollution were the key behavioral and environmental contributors of this global affliction.

Request Your Free C-Reactive Protein Testing Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=6719&type=smp

What Are the Key Firms That Are Driving Transformation in the C-Reactive Protein Testing Market?

Major companies operating in the c-reactive protein testing market include:

• Thermo Fisher Scientific Inc._x000D_

• F Hoffmann-La Roche AG_x000D_

• Danaher Corporation_x000D_

• Quest Diagnostics Incorporated_x000D_

• Siemens AG_x000D_

What Current Trends in the C-Reactive Protein Testing Market Should Industry Players Pay Attention To?

The c-reactive protein testing market is experiencing a key trend of technological innovation within its measuring devices. Major players in this market are concentrating on delivering technologically innovative solutions in order to solidify their market standing. They are incorporating next-generation c-reactive testing technologies into their methods and developing advanced solutions that offer high output and multiple use capabilities. For instance, Aidian, a diagnostics testing firm based in Finland, launched the QuikRead go wrCRP & wrCRP+Hb kits in February 2022. The kit allows for the consistent production of two results, covering a broad spectrum of CRP and Hb, from just one sample and one analysis. This broad-scale CRP test enables evaluations of conditions such as neonatal sepsis, assessment of disease severity in cases of COPD (chronic obstructive pulmonary disease), and assistance in cardiovascular risk analysis.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report

Which Key Segments Define the Structure of the C-Reactive Protein Testing Market and Their Growth Potential?

The c-reactive protein testing market covered in this report is segmented –

1) By Assay Type: Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Immunoturbidimetric Assays

2) By Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, Cancer, Other Applications

3) By End Use: Clinics, Hospitals, Diagnostic Laboratories

Subsegments:

1) By Enzyme-Linked Immunosorbent Assay (ELISA): Direct ELISA, Indirect ELISA, Sandwich ELISA

2) By Chemiluminescence Immunoassay (CLIA): Luminometer-Based CLIA, Automated CLIA Systems

3) By Immunoturbidimetric Assays: Nephelometry-Based Immunoturbidimetric Assays, Latex Agglutination Immunoturbidimetric Assays

What Regions Are Driving Expansion in the C-Reactive Protein Testing Market?

North America was the largest region in the c-reactive protein testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the c-reactive protein testing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

How Is the C-Reactive Protein Testing Market Categorized and Defined in the Industry?

C-reactive protein testing measures the level of c-reactive protein (CRP) in the blood. CRP is a liver-produced protein released into the bloodstream due to inflammation. When the body is wounded or infected, inflammation is the body’s way of protecting the tissues. CRP testing is generally used to diagnose inflammation caused due to an infection.

Browse Through More Similar Reports By The Business Research Company:

Protein Expression Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/protein-expression-global-market-report

Oral Biologics & Biosimilar Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/oral-biologics-and-biosimilar-drug-global-market-report

Protein Labeling Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/protein-labelings-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: